These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4073090)

  • 41. Ticarcillin-clavulanate therapy for bacterial skin and soft tissue infections.
    File TM; Tan JS
    Rev Infect Dis; 1991; 13 Suppl 9():S733-6. PubMed ID: 1925317
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative disk and broth dilution susceptibility test results with ticarcillin and timentin against Pseudomonas aeruginosa and Pseudomonas maltophilia.
    Traub WH; Spohr M
    Chemotherapy; 1987; 33(5):340-6. PubMed ID: 3117502
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antibacterial effects of ticarcillin/clavulanic acid in animal models of infection.
    Boon RJ; Beale AS; Sutherland R
    J Antimicrob Chemother; 1986 May; 17 Suppl C():41-6. PubMed ID: 3087934
    [TBL] [Abstract][Full Text] [Related]  

  • 44. European experience of timentin in combination with aminoglycosides as empirical treatment in febrile neutropenic patients.
    Croydon E; Weerts D
    Chemioterapia; 1987 Jun; 6(2 Suppl):405-7. PubMed ID: 3334585
    [No Abstract]   [Full Text] [Related]  

  • 45. Ticarcillin/clavulanic acid (Timentin) compared to metronidazole/netilmicin in preventing postoperative infection after elective colorectal surgery.
    Blair JE; McLeod RS; Cohen Z; Devlin HR
    Can J Surg; 1987 Mar; 30(2):120-2. PubMed ID: 3548930
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ticarcillin-clavulanic acid therapy in severe infections.
    Van der Auwera P; Legrand JC
    Drugs Exp Clin Res; 1985; 11(11):805-13. PubMed ID: 3836862
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Therapeutic efficacy of timentin and augmentin versus silvadene in burn wound infections.
    Heggers JP; McHugh T; Zoellner S; Boertman JA; Niu XT; Robson MC; Velanovich V
    J Burn Care Rehabil; 1989; 10(5):421-4. PubMed ID: 2793920
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Ticarcillin plus clavulanic acid versus moxalactam in the treatment of skin and soft tissue infections.
    Rao B; See RC; Chuah SK; Bansal MB; Lou MA; Thadepalli H
    Am J Med; 1985 Nov; 79(5B):126-9. PubMed ID: 4073078
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Ticarcillin disodium and clavulanate potassium in the treatment of post-cesarean-section endomyometritis.
    Sanders CV; Pastorek JG; Miller JM; Aldridge KE
    J Reprod Med; 1988 Jun; 33(6 Suppl):584-7. PubMed ID: 3260949
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The treatment of endomyometritis.
    Yonekura ML
    J Reprod Med; 1988 Jun; 33(6 Suppl):579-83. PubMed ID: 3260948
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of clavulanic acid/ticarcillin on severe infections accompanying hematological diseases].
    Urabe A; Takaku F; Kitagawa S; Miura Y; Dan K; Nomura T; Masuda M; Mizoguchi H; Yano T; Toyama K
    Jpn J Antibiot; 1987 Apr; 40(4):749-58. PubMed ID: 3613092
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacokinetics of the combination of ticarcillin with clavulanic acid in renal insufficiency.
    Dalet F; Amado E; Cabrera E; Donate T; del Rio G
    J Antimicrob Chemother; 1986 May; 17 Suppl C():57-64. PubMed ID: 3722047
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Infection in women. Clinical experience with beta-lactamase inhibitors.
    Holloway WJ
    J Reprod Med; 1988 Jun; 33(6 Suppl):595-7. PubMed ID: 3294405
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics and bacteriological efficacy of ticarcillin-clavulanic acid (timentin) in experimental Escherichia coli K-1 and Haemophilus influenzae type b meningitis.
    Syrogiannopoulos GA; Al-Sabbagh A; Olsen KD; McCracken GH
    Antimicrob Agents Chemother; 1987 Sep; 31(9):1296-300. PubMed ID: 3314696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Treatment of skin, skin structure, bone, and joint infections with ceftazidime.
    Gentry LO
    Am J Med; 1985 Aug; 79(2A):67-74. PubMed ID: 3895921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of penetrating abdominal trauma and gynecologic infections.
    Levine DP; Wilson RF
    J Reprod Med; 1988 Jun; 33(6 Suppl):598-602. PubMed ID: 3294406
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Biological efficacy and stability of diluted ticarcillin-clavulanic acid in the topical treatment of Pseudomonas aeruginosa infections.
    Bateman FL; Moss SM; Trott DJ; Shipstone MA
    Vet Dermatol; 2012 Apr; 23(2):97-102, e22. PubMed ID: 22050006
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of ticarcillin/clavulanate (Timentin) in the management of pediatric infections. Introduction.
    Nelson JD; McCracken GH
    Pediatr Infect Dis J; 1998 Dec; 17(12):1183-4. PubMed ID: 9877380
    [No Abstract]   [Full Text] [Related]  

  • 59. Comparison of ticarcillin plus clavulanic acid with cefoxitin in the treatment of female pelvic infection.
    Pastorek JG; Aldridge KE; Cunningham GL; Faro S; Graffeo S; McNeeley GS; Tan JS
    Am J Med; 1985 Nov; 79(5B):161-3. PubMed ID: 4073084
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Etiology and treatment of post-cesarean-section endometritis after cephalosporin prophylaxis.
    Hillier S; Watts DH; Lee MF; Eschenbach DA
    J Reprod Med; 1990 Mar; 35(3 Suppl):322-8. PubMed ID: 2181119
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.